-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
January 12, American Cancer Society journal CA: A Cancer Journal for
Clinicians publishes its annual report on cancer statistics: Cancer Statistics
In 2023, new cancer cases and deaths
in the United States are expected in 2023.
By 2023, 1958310 new cancer cases and 609,820 cancer deaths are expected to occur in the United States
.
Cancer mortality continued to decline from 2019 to 2020 (1.
5% decline), an overall decline of 33% since 1991, and an estimated 3.
8 million deaths
averted.
The COVID-19 pandemic has caused delays in cancer diagnosis and treatment due to medical facility closures, job losses, insurance disruptions
, and fear of contracting COVID-19.
Although the peak of COVID-19, the most impactful year of 2020, has passed, healthcare delivery has not fully recovered
.
For example, oncology surgery at Massachusetts General Hospital was 72 percent in the second half of 2020 compared to 84 percent
in 2021.
Delays in diagnosis and treatment may lead to an increase
in the proportion of advanced disease and mortality.
This time, Cancer
Statistics 2023 estimates the number of new cancer cases and deaths in the United States this year, as well as a comprehensive overview
of cancer occurrence based on the latest population data on cancer incidence and mortality.
in the proportion of advanced disease and mortality.
In 2023, about 5,370 new cases and 1,670 deaths are expected every day
In 2023, about 5,370 new cases and 1,670 deaths are expected every dayIn total, the United States is expected to have about 1958310 new cancer cases in total, which equates to about 5,370 new cases
per day.
In addition, there will be approximately 55,720 new cases of ductal carcinoma in situ in women and 89,070 new cases of melanoma in situ
of the skin.
Among them, men (40.
9%) have a slightly higher lifetime probability of developing invasive cancer than women (39.
1%)
.
Top 10 major cancer types in the United States in 2023 with estimated new cancer cases by sex
By 2023, 609,820 people will die of cancer in the United States, equivalent to 1,670 deaths
every day.
Lung cancer, prostate and colorectal cancer in men and lung, breast and colorectal cancer in women die the most
.
The higher risk of most cancer types in men is thought to largely reflect exposure to carcinogenic environments and behavioral factors such as smoking
.
By 2023, of the 127,070 lung cancer deaths, about 103,000 (81%) will be directly caused by smoking, and another 3,560 will be caused by secondhand smoke
.
every day.
About 103,000 cases (81%) will be directly caused by smoking, with another 3,560 cases caused by secondhand smoke
.
Top 10 major cancer types of estimated cancer deaths by sex in the United States in 2023
Cancer mortality rates continue to decline, with an overall decline of 33 percent since 1991, reductions in smoking, and improvements in early detection and treatment of certain cancers leading to a decline
in cancer mortality.
The 5-year relative survival rate for all cancers increased from 49% in the mid-1970s to 68%
between 2012 and 2018.
Thyroid cancer (98%), prostate cancer (97%), testicular cancer (95%) and melanoma (94%) have the highest survival rates, and pancreatic cancer (12%), liver cancer and esophageal cancer (21%) have the lowest
survival rates.
From 2007 to 2014, the incidence of prostate cancer fell by about 40 percent
.
Since the mid-2000s, the incidence of breast cancer in women has slowly increased by about 0.
5%
per year.
Since 2006-2007, the incidence of lung cancer has declined at a steady rate, by 2.
6% per year for men and 1.
1%
per year for women.
The incidence of non-Hodgkin lymphoma declined by about 1% per year between 2015 and 2019, and melanoma and liver cancer have stabilized
.
Since the mid-1970s, the incidence of cervical cancer has fallen by more than
half as a result of widespread screening.
between 2012 and 2018.
prostate cancer
Trends in cancer incidence by sex in the United States, 1975 to 2019
Trends in cancer mortality by sex in the United States, 1930-2020
Cancer deaths
averted between 1991 and 2020.
The shaded areas in the figure indicate avoided deaths
.
The blue line represents the actual number of cancer deaths recorded each year; The red line represents the expected number of cancer deaths
if the cancer mortality rate remains at its peak.
1.
Lung cancerLung cancer is the leading cause
of cancer death.
Of the cancer deaths recorded in 2020, lung cancer was the leading cause of cancer death for men and women aged 50 and older, causing far more deaths than breast, prostate and colorectal cancer combined
.
Since 2006-2007, the incidence of lung cancer has declined steadily, by 2.
6% per year for men and 1.
1%
per year for women.
From 1990 to 2020, lung cancer mortality in men fell by 58%; From 2002 to 2020, lung cancer mortality among women fell by 36%.
The 3-year relative survival rate for all stages of lung cancer increased from 22% from 2004 to 2006 to 33% from 2016 to 2018, and the progression of non-small cell lung cancer (from 25% to 38%) far outpaced that of small cell lung cancer (from 9% to 12%)
.
Early lung cancer detection, advances in surgery, more accurate pathological staging, and the development of lung cancer-targeted immune drugs have led to improved
lung cancer survival.
Lung cancerLung cancer is the leading cause of cancer death in men and women aged 50 years and older
2.
Prostate Cancer: Prostate cancer alone accounts for 29%
of diagnoses of the most common cancers diagnosed by men in 2023.
From 2007 to 2014, the incidence of prostate cancer fell by about 40 percent due to a decline
in the diagnosis of localized tumors by PSA testing.
The prevalence declined after the U.
S.
Preventive Services Task Force (USPSTF) recommended screening for men aged 75 years and older in 2008, followed by screening all men in 2012
.
In 2018, the USPSTF recommended more targeted screening
using molecular markers and magnetic resonance imaging targeted biopsies for men aged 55-69 years, based on the reduction of overdiagnosis and overtreatment while early prostate cancer screening.
Prostate cancer alone accounts for 29%
of diagnoses.
In 2018, the USPSTF recommended more targeted biopsy
using molecular markers and magnetic resonance imaging for men aged 55 to 69 years.
3.
Since the mid-2000s, the incidence of breast cancer in women has slowly increased by about 0.
5% per year, a trend attributed in part to the continued decline in fertility and the increase
in overweight.
Female breast cancer mortality peaked in 1989 and has since declined by 43 per cent, owing to early diagnosis through mammograms and awareness-raising, as well as improved
treatment.
The rate of decline in breast cancer mortality has slowed in recent years, from 2 to 3 percent per year in the 1990s and 2000s to 1 percent
per year from 2011 to 2020.
breast cancer
4.
Colorectal cancer has the third highest incidence in both men and women and is the second most common cause
of cancer death.
Since 1980, the mortality rate has fallen by 55% for men and 61%
for women since 1969.
CRC mortality rates in women had been declining until 1969, but early data years did not rule out small bowel cancer deaths
.
In the last decade (2011-2020), CRC mortality has decreased by about 2%
per year.
However, youth mortality is on the rise; From 2005 to 2020, CRC mortality continued to increase by 1.
2% per year for people under 50 years of age, and 0.
6%
per year for people aged 50-54 years.
CRC mortality from colorectal cancer is decreasing by about 2%
per year.
CRC mortality continues to increase by 1.
2% per year for people under 50 years of age and 0.
6%
per year for people aged 50-54 years.
5.
Pancreatic cancer is the third leading cause of cancer deaths in men and women, with mortality rates in men increasing slowly, from 12.
1 (per 100,000 men) in 2000 to 12.
7 cases per 100,000 men in 2020, but remained relatively stable for women at 9.
3-9.
6 cases per 100,000 women
.
pancreatic cancer
6.
Since the mid-1970s, the incidence of cervical cancer has fallen by more than
half due to widespread screening.
Cervical cancer is one of the most preventable cancers, and HPV vaccination can almost eliminate cervical cancer
.
HPV vaccination for cervical cancer can almost eliminate cervical cancer
.
7.
Cancer in children and adolescents
Cancer in children and adolescents
In the United States, cancer is the second most common cause of death among children aged 1-14 years, after accidents, and the fourth most common cause of death among adolescents (ages 15-19
).
By 2023, an estimated 9,910 children (from birth to 14 years of age) and 5,280 adolescents (aged 15-19) will be diagnosed with cancer, with 1,040 and 550 dying, respectively
.
About 1 in 260 children and adolescents will be diagnosed with cancer
before the age of 20.
Leukemia is the most common childhood cancer, accounting for 28% of cases, followed by brain and other neurological tumors (26%), nearly a third of which are benign or borderline malignant
.
, respectively.
Reference: https://doi.
org/10.
3322/caac.
21763
org/10.
3322/caac.
21763
